Article title | Author | Date |
---|---|---|
Study reveals surgical consequences of severe obesity | Labseeker | 2015-06-11 |
Merck teams up with llumina and Genea | Labseeker | 2015-06-11 |
FDA issues clearance for Angion Begin | Labseeker | 2015-06-11 |
New progress doubles the survival time of Cancel | Labseeker | 2015-06-11 |
VaxInnate begins phase II trial | Labseeker | 2015-06-05 |
Cancer screening increase may reflect Affordable Care Act | Labseeker | 2015-06-05 |
First phase of Amway's new Site | Labseeker | 2015-06-05 |
Study maps types of physical activity associated with better | Labseeker | 2015-06-05 |
WHO accepts Elafibranor as generic name | Labseeker | 2015-06-05 |
Elusys Therapeutics gets FDA acceptance for BLA of Anthim | Labseeker | 2015-06-03 |
© 2006-2015 Labseeker. All Rights Reserved.